Phase 3 Study of KHK7580 (A Clinical Study of KHK7580 in Subjects With Secondary Hyperparathyroidism Receiving Peritoneal Dialysis)
Phase of Trial: Phase III
Latest Information Update: 10 Aug 2017
At a glance
- Drugs Evocalcet (Primary)
- Indications Secondary hyperparathyroidism
- Focus Therapeutic Use
- Sponsors Kyowa Hakko Kirin
- 10 Aug 2017 Last checked against Japan Pharmaceutical Information Center - Clinical Trials Information.
- 02 Jul 2017 Status changed from recruiting to completed.
- 18 Sep 2015 New trial record